Danaher Corporation (DHR)
Cash ratio
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 4,615,000 | 2,078,000 | 5,864,000 | 5,995,000 | 2,586,000 |
| Short-term investments | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 6,807,000 | 6,798,000 | 8,274,000 | 8,389,000 | 8,140,000 |
| Cash ratio | 0.68 | 0.31 | 0.71 | 0.71 | 0.32 |
December 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($4,615,000K
+ $—K)
÷ $6,807,000K
= 0.68
Peer comparison
Dec 31, 2025
Company name
Symbol
Cash ratio
Danaher Corporation
DHR
0.68
Agilent Technologies Inc
A
0.76
Thermo Fisher Scientific Inc
TMO
0.67